Showing results (731-740 of 3,080) with videos related to

Sort By:
Pageof 308
Drug Safety|September 27, 2024
Safeguarding Patients in the AI Era: Ethics at the Forefront of PharmacovigilanceAshish Jain, Maribel Salas, Omar Aimer, et al.
Drug Safety|March 6, 2026
Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta-analysis of Safety and EffectivenessAgustín Ciapponi, Jamile Ballivian, Mabel Berrueta, et al.
Drug Safety|March 2, 2026
Genetically Informed Research Designs in Perinatal Pharmacoepidemiology: A Methodological OverviewAlexis C Carson, Mahmoud Zidan, Emilie Willoch Olstad, et al.
Drug Safety|June 28, 2023
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID StudyDavid R Cornblath, Pieter A van Doorn, Hans-Peter Hartung, et al.
Drug Safety|August 3, 2023
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical UtilityVijay Kara, Greg Powell, Olivia Mahaux, et al.
Drug Safety|July 8, 2023
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research StudyMichele Fusaroli, Francesco Salvo, Claire Bernardeau, et al.
Drug Safety|June 20, 2023
Provision and Characterization of a Corpus for Pharmaceutical, Biomedical Named Entity Recognition for Pharmacovigilance: Evaluation of Language Registers and Training Data SufficiencyJürgen Dietrich, Philipp Kazzer
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.
Drug Safety|April 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolYanning Wang, Celeste L Y Ewig, Nicole E Smolinski, et al.
Drug Safety|April 13, 2026
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation CenterAnjum Khurshid, David Kendrick, Haritha S Pillai, et al.
Pageof 308